IP Library Granted Patent US 9,718,921
Granted Patent B2
US 9,718,921 · App. 14/770,417 · Granted Aug 1, 2017

Amphiphilic derivatives of thioether containing block copolypeptides

Inventors: Timothy J. Deming (Los Angeles, CA); Jessica R. Kramer (Oakland, CA); April R. Rodriguez (Marina Del Rey, CA)
Assignee: The Regents of the University of California
C08G69/48A61K9/1273A61K47/34A61K47/42C08G69/10C08G69/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,718,921
App. No.
14/770,417
Granted
Aug 1, 2017
Kind
B2
Abstract

Methods for preparation of novel amphiphilic derivatives of thioether containing block copolypeptides with narrow chain length distributions are described. These block copolymers can be chemically modified by oxidation and alkylation of the thioether containing residues. These materials generate self-assembled micelles, vesicles and hydrogels, or emulsions with oil phases. These assemblies can be used to encapsulate and delivery therapeutic molecules. The assemblies can be taken up by cells to release molecules from the assemblies.

Claims (22)

1. A process for preparing an amphiphilic block copolypeptide with oxidized thioether groups comprising:

synthesizing a block copolypeptide wherein at least one of the blocks contains at least 3 consecutive hydrophobic amino acids selected from leucine, phenylalanine, alanine, isoleucine, valine, tyrosine, and tryptophan, and wherein at least one of the blocks contains at least 3 consecutive thioether containing amino acids selected from methionine, S-methyl-cysteine, S-ethyl-cysteine, S-allyl-cysteine, S-benzyl-cysteine, S-farnesyl-cysteine, S-propargyl-cysteine, S-methyl-homocysteine, S-ethyl-homocysteine, S-allyl-homocysteine, S-benzyl-homocysteine, S-farnesyl-homocysteine, and S-propargyl-homocysteine;

adding an oxidizing reagent to the block copolypeptide; and

reacting the block copolypeptide so that the majority of the thioether groups in the polypeptide are oxidized, thereby forming the amphiphilic block copolypeptide with oxidized thioether groups.

2. The process of claim 1 , wherein the thioether containing amino acids are methionine.

3. The process of claim 1 , wherein the thioether containing amino acids are one or more of S-methyl-cysteine, S-ethyl-cysteine, S-allyl-cysteine, S-benzyl-cysteine, S-farnesyl-cysteine, and S-propargyl-cysteine.

4. The process of claim 1 , wherein the thioether containing amino acids are one or more of the following: S-methyl-homocysteine, S-ethyl-homocysteine, S-allyl-homocysteine, S-benzyl-homocysteine, S-farnesyl-homocysteine, and S-propargyl-homocysteine.

5. The process of claim 1 , wherein the oxidized thioether groups in the amphiphilic block copolypeptide are one or more of the following: sulfoxide, and sulfone.

6. The process of claim 1 wherein the hydrophobic amino acids are one or more of L-leucine, L-phenylalanine, L-alanine, L-isoleucine, L-valine, L-tyrosine, and L-tryptophan.

7. The process of claim 1 , wherein the block copolypeptide is a diblock copolypeptide.

8. The process of claim 1 , wherein the block copolypeptide is a triblock copolypeptide.

9. The process of claim 1 , wherein the thioether containing amino acids are L-methionine.

10. The process of claim 1 , wherein the hydrophobic amino acids are L-leucine or L-phenylalanine.

11. The process of claim 1 , wherein the oxidizing reagent comprises H 2 O 2 .

12. The process of claim 1 , wherein the amphiphilic block copolypeptide with oxidized thioether groups is

poly(L-methionine-sulfoxide) 65 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ;

poly(Nε-trifluoroacetyl-L-lysine) 11 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ;

poly(Nε-trifluoroacetyl-L-lysine) 21 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ;

poly(L-lysine) 10 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ;

poly(L-lysine) 20 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ;

poly(L-homoarginine) 10 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 ; or

poly(L-homoarginine) 20 -block-poly(L-methionine sulfoxide) 55 -block-poly(L-leucine 0.5 -co-L-phenylalanine 0.5 ) 20 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 4, 2017
From: UNIVERSITY OF CALIFORNIA, LOS ANGELES
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 041245/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2015
From: DEMING, TIMOTHY J.; KRAMER, JESSICA R.; RODRIGUEZ, APRIL R.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 036509/0610 →
Continuity (2)
Provisional Application 61769702 · Feb 26, 2013
Related Publication 20160002405A1 · Jan 7, 2016